• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Apria Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    3/24/22 5:05:51 PM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    8-K
    false 0001735803 0001735803 2022-03-24 2022-03-24

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of Earliest Event Reported): March 24, 2022

     

     

    Apria, Inc.

    (Exact Name of Registrant as Specified in its Charter)

     

     

     

    Delaware   001-40053   82-4937641
    (State or Other Jurisdiction
    of Incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

    7353 Company Drive

    Indianapolis, Indiana 46237

    (Address of Principal Executive Offices) (Zip Code)

    (800) 990-9799

    (Registrant’s Telephone Number, Including Area Code)

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol

     

    Name of each exchange
    on which registered

    Common Stock, par value $0.01 per share   APR   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.07

    Submission of Matters to a Vote of Security Holders.

    On March 24, 2022, Apria, Inc. (“Apria”) held its special meeting of stockholders (the “Special Meeting”) in connection with the Agreement and Plan of Merger, dated January 7, 2022 (as amended or modified from time to time, the “Merger Agreement”), among Apria, Owens & Minor, Inc. (“Parent”) and StoneOak Merger Sub Inc. (“Merger Sub”), an indirect, wholly-owned subsidiary of Parent, pursuant to which Merger Sub will be merged with and into Apria and Apria will survive the merger as an indirect, wholly-owned subsidiary of Parent (the “Merger”). As of the close of business on February 17, 2022, the record date for the Special Meeting, there were 35,644,720 shares of Apria’s common stock issued and outstanding, of which 31,354,324 shares (representing approximately 88% of the shares of Apria’s common stock issued and outstanding on the record date) were represented in person or by proxy at the Special Meeting. The results for each of the matters voted on at the Special Meeting are set forth below:

    Proposal I - Adoption of the Merger Agreement (the “Merger Proposal”).

     

    Votes Cast For

     

    Votes Cast Against

     

    Abstentions

     

    Broker Non-Votes

    31,271,616

     

    28,467

     

    54,241

      N/A

    The Merger Proposal was approved by the stockholders, by an affirmative vote of the holders of approximately 88% of the voting power of the shares of Apria’s common stock outstanding as of the close of business on the record date.

    Proposal II - Approval, on a non-binding, advisory basis, of certain compensation that will or may be paid by Apria to its named executive officers that is based on or otherwise relates to the Merger (the “Named Executive Officer Merger-Related Compensation Proposal”).

     

    Votes Cast For

     

    Votes Cast Against

     

    Abstentions

     

    Broker Non-Votes

    28,371,975

     

    1,811,299

     

    1,171,050

      N/A

    The Named Executive Officer Merger-Related Compensation Proposal was approved by the stockholders, on an advisory basis, by the holders of approximately 91% of the voting power of the shares of Apria’s common stock present in person or represented by proxy at the Special Meeting.

    Proposal III - Adjournment of the Special Meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Apria, including for the purpose of soliciting additional votes for the approval of the Merger Proposal if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).

    In connection with the Special Meeting, Apria solicited proxies with respect to the Adjournment Proposal. Because there were sufficient votes from Apria stockholders to approve the Merger Proposal, adjournment of the Special Meeting was unnecessary and the Adjournment Proposal was not called.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

          APRIA, INC.
    Date: March 24, 2022      

    /s/ Michael-Bryant Hicks

          Name: Michael-Bryant Hicks
         

    Title:   Executive Vice President, General Counsel and Secretary

    Get the next $APR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings

    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Walker Robert P. returned $192,450 worth of shares to the company (5,132 units at $37.50), closing all direct ownership in the company (tax liability)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:49 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Apria Holdings Llc sold $532,031,812 worth of shares (14,187,515 units at $37.50)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:15 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Snyder Lynn Shapiro to satisfy withholding obligation

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:20 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    SEC Filings

    View All

    SEC Form 15-12B filed by Apria Inc.

    15-12B - Apria, Inc. (0001735803) (Filer)

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Apria Inc.

    25-NSE - Apria, Inc. (0001735803) (Subject)

    3/29/22 8:55:14 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Apria Inc.

    S-8 POS - Apria, Inc. (0001735803) (Filer)

    3/29/22 8:35:01 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Apria downgraded by UBS with a new price target

    UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50

    1/11/22 6:43:54 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    1/10/22 7:15:48 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    11/19/21 7:12:27 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apria Announces Financial Results for Fourth Quarter and Full Year 2021

    INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth

    2/28/22 6:30:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

    INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,

    2/24/22 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    $APR
    Financials

    Live finance-specific insights

    View All

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    Apria to Announce Third Quarter 2021 Financial Results

    INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni

    10/21/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria to Announce Second Quarter 2021 Financial Results

    INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen

    7/22/21 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Apria Inc. (Amendment)

    SC 13G/A - Apria, Inc. (0001735803) (Subject)

    4/8/22 4:04:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    3/10/22 5:01:54 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    2/14/22 4:06:09 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    Apria Appoints Christopher G. Lee as Chief Accounting Officer

    INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a

    10/4/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care